Skip to main content
. Author manuscript; available in PMC: 2019 Aug 1.
Published in final edited form as: Clin Transplant. 2018 Jul 11;32(8):e13328. doi: 10.1111/ctr.13328

Figure 4.

Figure 4

Risk-adjusted survival one year after initial evaluation for advanced therapies in patients with Medicare or Private insurance not listed for HT, according to therapy. DT LVAD, destination therapy LVAD; OMM, optimal medical management.